Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05337137
Title A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer (RELATIVITY-106)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb

hepatocellular carcinoma


Bevacizumab + Nivolumab + Relatlimab

Bevacizumab + Nivolumab

Age Groups: adult | senior
Covered Countries USA | FRA | ESP | DEU | CAN

No variant requirements are available.